DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Haab F, Stewart L, Dwyer P.
Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.
Eur Urol 2004;
45: 420-429
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.